Bulk Inquiry
iMDK
Axon 2258
CAS:
881970-80-5
Purity:
99%
- Soluble in DMSO
- MF: C21H13FN2O2S
- MW: 376.4
Description
iMDK is a midkine (MDK) expression inhibitor that selectively suppresses MDK in H441 lung adenocarcinoma cells without inhibiting the homologous growth factor pleiotrophin (PTN). It induces apoptosis in MDK-expressing cells through PI3K/Akt pathway suppression while sparing VEGF expression.
Midkine is a heparin-binding growth factor implicated in tumor growth, inflammation, angiogenesis and tissue repair. iMDK is useful for studying MDK-dependent survival signaling and separating midkine biology from related growth-factor pathways.
Key Features
- Selective inhibitor of midkine expression
- Suppresses PI3K/Akt signaling in MDK-expressing cells
- Induces apoptosis in H441 lung adenocarcinoma cells
- Does not inhibit PTN or VEGF expression in reported assays
Applications
- Midkine biology research
- Lung cancer survival-pathway studies
- PI3K/Akt signaling assays
- Growth-factor selectivity studies
More Information
| Parent CAS No. | 881970-80-5 |
|---|---|
| Chemical Name | 3-(2-(4-fluorobenzyl)imidazo[2,1-b]thiazol-6-yl)-2H-chromen-2-one |
| SMILES | C1(=O)OC2=CC=CC=C2C=C1C1=CN2C=C(CC3=CC=C(F)C=C3)SC2=N1 |
| MFCD | N.A. |
| InChi | InChI=1S/C21H13FN2O2S/c22-15-7-5-13(6-8-15)9-16-11-24-12-18(23-21(24)27-16)17-10-14-3-1-2-4-19(14)26-20(17)25/h1-8,10-12H,9H2 |
| InChiKey | IWFKQTWYILKFGE-UHFFFAOYSA-N |
| CID | 15991416 |
| Short Description | Midkine expression inhibitor |
Other Categories
Get a Quote for
Loading...